Schering Sues Apotex Over Nasonex ANDA
Merck & Co. Inc. unit Schering Corp. has accused Canadian drugmaker Apotex Inc. of infringing three patents related to Nasonex nasal spray by submitting an abbreviated new drug application for permission...To view the full article, register now.
Already a subscriber? Click here to view full article